Buy SpiceJet

Investors looking for a smart return over next 1 year should look at investing in this small cap scrip.Starting from the low of Rs.24 the share price went to scale 52 week high of Rs.94 and is now correcting.

Investment rationale :

1. Upcoming aggressive push
2. Reduction of Rs.1200 crore debt
3. Profit of Rs.275 crore in recent quarter
4. Low aviation fuel cost
5. High profitability
6. Strong and aggressive management

Returns in the last 1 year

• BSE
 
• NSE

on   dd  01  02  03  04  05  06  07  08  09  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31 

  mm  Jan  Feb  Mar  Apr  May  Jun  Jul  Aug  Sep  Oct  Nov  Dec 

  yyyy  20002001200220032004200520062007200820092010201120122013201420152016 

1 week  |  1 month  |  3 month  |  1 year  |  2 year

	1 YEAR	CURRENT	%GAIN / LOSS
Open Price	22.00	90.70
High Price	22.20	90.90
Low Price	21.50	85.65
Last Price	21.80	87.30	300.46
Volume	4,447,627	18,483,204	315.57

The scrip gave a 3x return compared to last year price of Rs.24

Recommendation :

The company share price is trading near to the highest recorded recently and there is plenty of steam still left in this scrip.

Buy Range - Rs. 75-86
Holding period - 12 to 15 months
Returns - 100%

We strongly recommend a buy on the scrip on dips.  The only negative for the scrip is that it is not listed on NSE which can happen once the company decides to list there too.

Raghav

Smart Investor - Equity Research

No.24 Pattamal Plaza
3rd Cross Kammanahalli
BANGALORE 560084

Mobile / Whatsapp -08105-737-966

intellinvestor@gmail.com
www.twitter.com/SmartInvestor

Buy - Morepen Labs

Here is a small cap recommendation from Smart Investor 

Background :

Morepen Laboratories Limited is an India-based pharmaceutical company. The Company operates through four segments; they are Active Pharmaceutical Ingredients (API), Domestic Formulations, Diagnostics and Over the Counter (OTC). The API segment has developed new products like Sitagliptin Phosphate, Rosuvastatin Calcium, Olmesartan Medoxomil and Aliskiren in the Research and Development laboratory. 

The Domestic Formulations segment markets over 100 branded formulations in 8 major therapeutic segments. The Diagnostics segment markets under its own brand name Clinical and Home Health devices and Blood Banking machines. The OTC segment market brands like Burnol ,Lemolate, Sat-Isabgol, Option -72, Head-X, Fever-X , C- Candy and other Over the Counter (OTC) products. The Company has 3 manufacturing facilities, for manufacture of API, formulations and OTC products with international standings.

Source : Reuters

Trend : 

Short term : Down
Medium term : Up
Long term : Up

Return ratios :

The stock has given a steady returns and created wealth to the investors

1 month =  25%
3 months = 200%
6 months = 300%
12 months = 360%

Recommendation :

There has been turn around in fortunes of this company and one can expect decent up move from here.  Buy around Rs.30 levels and hold for a target of Rs.60 holding period of 12 months

Raghav

Smart Investor

No.24 Pattamal Plaza
3rd Cross Kammanahalli
BANGALORE 560084

Mobile / Whatsapp -08105-737-966

intellinvestor@gmail.com
www.twitter.com/SmartInvestor